While Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX) In Russell 3000® and Russell Microcap® Indexes, Inpixon (NASDAQ: INPX) Included In The Russell Microcap® Index

June 30, 2021

Lineage Cell Therapeutics Inc (NYSEAMERICAN: LCTX), a clinical-stage biotechnology company involved in developing allogeneic cell therapies for unmet medical needs, in an official statement, announced that the company had made it to broad-market Russell 3000® Index as well as the Russell Microcap® Index. Inpixon (NASDAQ: INPX) included in Russell Microcap® Index Inpixon (NASDAQ: INPX), the Indoor Intelligence™ company, announced that it had made it to the Russell Microcap® Index. By…

Read More >>